Dose Archives - Page 2 of 6 - World Asthma Foundation

April 1, 2016

A daily dose of sunshine while pregnant could help reduce child’s asthma – Malay Mail Online

A daily dose of sunshine while pregnant could help reduce child's asthma
Malay Mail Online
Sufficient Vitamin D during the second trimester of pregnancy could help reduce a child's risk of developing asthma says a new American study. — AFP picKANSAS, April 1 — Sufficient Vitamin D during the second trimester of pregnancy could help reduce …

View full post on asthma – Google News

December 11, 2015

Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma

Condition: Mild Asthma
Interventions: Drug: 90 mcg Reference Product; Drug: 180 mcg Reference Product; Drug: 90 mcg Test Product; Drug: Placebo
Sponsor: Cipla Ltd.
Not yet recruiting – verified December 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

May 30, 2015

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Condition: Bronchial Asthma
Interventions: Drug: Intravenous magnesium sulfate; Drug: Inhaled budesonide; Drug: normal saline
Sponsor: Hamad Medical Corporation
Recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

October 26, 2014

Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in Environmental Exposure Chamber

Condition: Allergic Rhino-Conjunctivitis
Intervention: Drug: AllerT
Sponsors: Anergis; Inflamax Research Incorporated
Recruiting – verified October 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

October 8, 2014

Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

Condition: Healthy
Interventions: Drug: Tiotropium/Salmeterol; Drug: Serevent® Diskus®; Drug: Spiriva®
Sponsor: Boehringer Ingelheim
Completed – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

September 20, 2014

Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma

Conditions: Healthy; Asthma
Interventions: Drug: JNJ-43260295; Drug: Placebo; Other: Nasal Allergen Challenge
Sponsor: Janssen Research & Development, LLC
Not yet recruiting – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

September 11, 2014

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

Condition: Asthma
Interventions: Drug: Ipratropium bromide; Drug: Placebo; Drug: Salbutamol
Sponsor: Boehringer Ingelheim
Terminated – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

July 13, 2014

Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma

Condition: Asthma
Interventions: Drug: Berodual® Respimat®, low dose; Drug: Berodual® Respimat®, high dose; Drug: Berodual® MDI
Sponsor: Boehringer Ingelheim
Completed – verified July 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

June 28, 2014

Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma

Condition: Asthma
Interventions: Drug: Fenoterol MDI; Drug: DSCG MDI
Sponsor: Boehringer Ingelheim
Terminated – verified June 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

May 26, 2014

FDA approves Teva’s QVAR with dose counter to treat asthma – Pharmaceutical Business Review

FDA approves Teva's QVAR with dose counter to treat asthma
Pharmaceutical Business Review
The US Food and Drug Administration (FDA) has approved the use of Teva Pharmaceutical's QVAR (beclomethasone dipropionate HFA) with a dose counter for the ongoing treatment of asthma as a preventative therapy in patients five years of age and older.

View full post on asthma – Google News